Kalexsyn Selects Synthematix’s Arthur™ Suite Electronic Notebook for Knowledge Retention and Chemistry Planning

Synthematix®, Inc., a provider of chemistry reaction planning and knowledge management systems, announced today that Kalexsyn, Inc. has selected the Arthur™ Suite for deployment throughout its chemistry operations. Kalexsyn provides high value medicinal chemistry services to the pharmaceutical industry.

“Synthematix is leading the way in cheminformatics software with the Arthur™ Suite,” said Dr. Robert Gadwood, CEO of Kalexsyn. “We are a young, rapidly growing company, and we want to capture institutional knowledge from the start. The Arthur™ Suite provides our chemists with the best chemistry software solution available and empowers them to work better and smarter than ever before. The Synthematix software delivers all the important features of an electronic notebook and much more.”

“Kalexsyn has been founded and staffed by some of the world’s leading medicinal chemists,” said Steve Jones, CEO of Synthematix. “The Arthur™ Suite will leverage their collective medicinal chemistry experience and improve their attractiveness to clients by enabling knowledge sharing and accelerating their drug discovery efforts.”

“As we grow, we want to capture all the knowledge of our company and retain it for future scientists,” said David Zimmermann, president of Kalexsyn. “Also, the Arthur™ Suite gives us the ability to communicate in real time with our customers for more effective and efficient delivery of information about their work as it is being done.”

About Synthematix

Synthematix, Inc. (www.synthematix.com ), based in Research Triangle Park, NC, provides fully integrated software solutions for chemists. Synthematix’s proprietary technology allows chemists to conceive, design, calculate, record and report experiments. Our unparalleled tools consist of the Arthur™ Suite of informatics products, as well as Substructure Search technology. These tools and databases increase chemistry-intensive organizations’ flexibility, effectiveness and efficiency. Arthur™ users include ActivBiotics, Cubist Pharmaceuticals, Eisai Research Institute, Incyte Corporation, Inspire Pharmaceuticals, Plexxikon Corporation, Sigma Aldrich and other leading chemistry organizations.

About Kalexsyn

Kalexsyn, Inc. (www.kalexsyn.com ), based in Kalamazoo, MI, is a high energy, high performance organization providing medicinal chemistry services and consulting services to companies engaged in the drug discovery process. They have expertise in all aspects of medicinal chemistry, including organic synthesis, physical property modification, analog strategies and diversification of compound collections. Their services accelerate a client’s drug discovery program at all stages, including early SAR studies of screening hits, optimization of leads, and synthesis of intermediates and building blocks.

This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Companies’ expectations, goals, beliefs, intentions and the like, which involve assumptions regarding Company operations and conditions in the markets the Companies serve. The Companies do not undertake any obligation to update these forward-looking statements.